Columbus-based Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute has appointed W. Kimryn Rathmell, MD, PhD, as CEO.
Dr. Rathmell will step into the role May 27, pending board approval, according to an April 23 news release from Ohio State.
She most recently served as a director for the National Cancer Institute under the Biden Administration, launching the Early-Onset Cancer Initiative and focusing on improving health equity in cancer care, the release said.
Pending board approval, she will also serve as Ohio State’s inaugural Jeri B. Block and Robert H. Schottenstein Distinguished Chair in Cancer, a $10 million endowed position.